المؤلفون: Kleer JS; Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Internal Medicine, University Hospital, Basel, Switzerland., Klehr J; Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland., Dubler D; Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland., Infanti L; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland., Chizzolini C; Department of Pathology and Immunology, University Hospital, Geneva, Switzerland., Huynh-Do U; Department of Nephrology and Hypertension, University Hospital, Bern, Switzerland., Ribi C; Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, Lausanne, Switzerland., Trendelenburg M; Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Internal Medicine, University Hospital, Basel, Switzerland.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 29; Vol. 15, pp. 1447991. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Erythematosus, Systemic*/immunology , Lupus Erythematosus, Systemic*/blood , Complement Factor H*/metabolism , Complement Factor H*/immunology , Autoantibodies*/blood , Autoantibodies*/immunology, Humans ; Female ; Male ; Adult ; Middle Aged ; Complement C3b Inactivator Proteins/genetics ; Young Adult ; Aged ; Case-Control Studies ; Adolescent ; Blood Proteins

المؤلفون: Prantl L; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Heider P; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bergmeister L; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Calana K; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bohn JP; Department of Internal Medicine V, Hematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Banki Z; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria., Bosch A; 2bind GmbH, Regensburg, Germany., Plach M; 2bind GmbH, Regensburg, Germany., Huber G; Sirion Biotech GmbH, Gräfelfing, Germany., Schrödel S; Sirion Biotech GmbH, Gräfelfing, Germany., Thirion C; Sirion Biotech GmbH, Gräfelfing, Germany., Stoiber H; Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.; Lysomab GmbH, Schwaz, Austria.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 22; Vol. 15, pp. 1379023. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20*/immunology , Antigens, CD20*/genetics , Complement Factor H*/immunology , Complement Factor H*/metabolism , Complement Factor H*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/immunology , Antibody-Dependent Cell Cytotoxicity* , Rituximab*/pharmacology, Humans ; Antibodies, Monoclonal, Humanized/pharmacology ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/immunology ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Cell Line, Tumor

المؤلفون: Kurihara S; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Yamaguchi A; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Sonoda K; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Yamada Y; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Harada M; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Hashimoto K; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan., Shimojo H; Department of Pathology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan., Ikeda Y; Division of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan., Kamijo Y; Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. yujibeat@shinshu-u.ac.jp.

المصدر: BMC nephrology [BMC Nephrol] 2024 Jul 15; Vol. 25 (1), pp. 224. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Atypical Hemolytic Uremic Syndrome*/drug therapy , Antibodies, Monoclonal, Humanized*/therapeutic use , Complement Factor H*, Humans ; Female ; Middle Aged ; Complement C5/antagonists & inhibitors ; Kidney/pathology

المؤلفون: Zhu C; Department of Cardiovascular Medicine, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, China., Guo L; Department of Radiology, 2nd Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Yuan Y; Department of emergency, 2nd Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Guo H; Department of Cardiology, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. guohao677@163.com.

المصدر: Molecular biology reports [Mol Biol Rep] 2024 Aug 06; Vol. 51 (1), pp. 888. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Essential Hypertension*/genetics , Genetic Predisposition to Disease* , Complement Factor H*/genetics , Polymorphism, Single Nucleotide*/genetics , Asian People*/genetics , Genotype*, Humans ; Male ; Middle Aged ; Female ; China ; Gene Frequency/genetics ; Aged ; Case-Control Studies ; Adult ; Hypertension/genetics ; Genetic Association Studies/methods ; Alleles ; Blood Pressure/genetics

المؤلفون: Thangaraju S; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Khandelwal P; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Mishra K; Department of Pediatrics, Chacha Nehru Bal Chikitsalaya, Delhi, India., Kumar M; Department of Pediatrics, Chacha Nehru Bal Chikitsalaya, Delhi, India., Puraswani M; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Saini R; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Hari P; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Coshic P; Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India., Sinha A; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India., Bagga A; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India. arvindbagga@hotmail.com.

المصدر: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Jul; Vol. 39 (7), pp. 2091-2097. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Atypical Hemolytic Uremic Syndrome*/therapy , Atypical Hemolytic Uremic Syndrome*/immunology , Atypical Hemolytic Uremic Syndrome*/blood , Complement Factor H*/immunology , Plasma Exchange*/methods, Child ; Child, Preschool ; Humans ; Male ; Antibodies, Monoclonal, Humanized/therapeutic use ; Autoantibodies/blood ; Autoantibodies/immunology ; Immunosuppressive Agents/therapeutic use ; Mycophenolic Acid/therapeutic use ; Mycophenolic Acid/administration & dosage ; Prospective Studies ; Treatment Outcome

المؤلفون: Kang YH; Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; MediMabBio Inc., Pangyo Business Growth Centre, Gyeonggi-do, Republic of Korea., Varghese PM; School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India., Aiyan AA; Department of Veterinary Medicine (CAVM), United Arab Emirates University, Al Ain, United Arab Emirates., Pondman K; Applied Microfluidics for BioEngineering Research, MESA+ Institute for Nanotechnology & TechMed Centre, University of Twente, Enschede, Netherlands., Kishore U; Department of Veterinary Medicine (CAVM), United Arab Emirates University, Al Ain, United Arab Emirates.; Zayed Centre for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates., Sim RB; Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 12; Vol. 15, pp. 1368852. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Factor H*/metabolism , Complement Factor H*/immunology , Fibrin*/metabolism , Blood Coagulation* , Complement C1q*/metabolism , Complement C1q*/immunology , Complement Pathway, Classical*/immunology, Humans ; Protein Binding ; Complement Activation/immunology ; Blood Platelets/immunology ; Blood Platelets/metabolism

المؤلفون: Mori F; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Pascali G; Biosciences, Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW, Australia.; School of Chemistry, University of New South Wales, Kensington, NSW, Australia., Berra S; Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Milan, Italy., Lazzarotti A; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Panetta D; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Rocchiccioli S; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Ceccherini E; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Norelli F; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Morlando A; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Donadelli R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Clivio A; Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Milan, Italy., Farina C; Research and Innovation, Kedrion Biopharma, Lucca, Italy., Noris M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Salvadori PA; Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 06; Vol. 15, pp. 1334151. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Factor H*/metabolism , Complement Factor H*/genetics , Complement C3* , Mice, Knockout*, Animals ; Humans ; Mice ; Disease Models, Animal ; Proof of Concept Study ; Mice, Inbred C57BL

المؤلفون: Tschongov T; Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Konwar S; Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Busch A; Eleva GmbH, Freiburg, Germany., Sievert C; Eleva GmbH, Freiburg, Germany., Hartmann A; Department of Infection Biology, Leibniz Insitute for Natural Product Research and Infection Biology, Jena, Germany., Noris M; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Dacco', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Gastoldi S; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Dacco', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Aiello S; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Dacco', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Schaaf A; Eleva GmbH, Freiburg, Germany., Panse J; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.; Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD) Germany Pauwelsstrasse 30, Aachen, Germany., Zipfel PF; Department of Infection Biology, Leibniz Insitute for Natural Product Research and Infection Biology, Jena, Germany.; Institute of Microbiology, Friedrich-Schiller-University, Jena, Germany., Dabrowska-Schlepp P; Eleva GmbH, Freiburg, Germany., Häffner K; Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1383123. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Factor H*/metabolism , Complement Factor H*/genetics, Humans ; Animals ; Mice ; Half-Life ; Polysaccharides/metabolism ; Bryopsida/metabolism ; Bryopsida/genetics ; Glycosylation ; Recombinant Proteins ; Mice, Knockout ; Mice, Inbred C57BL ; Male

المؤلفون: Rabeeah I; Pirbright Institute, Woking, United Kingdom.; Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Billington E; Pirbright Institute, Woking, United Kingdom., Nal B; Aix-Marseille Université, CNRS, INSERM, CIML, Marseille, France., Sadeyen JR; Pirbright Institute, Woking, United Kingdom., Pathan AA; Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Iqbal M; Pirbright Institute, Woking, United Kingdom., Temperton NJ; Viral Pseudotype Unit, University of Kent, Chatham, United Kingdom., Zipfel PF; Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.; Institute of Microbiology, Friedrich Schiller University, Jena, Germany., Skerka C; Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany., Kishore U; Department of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.; Zayed Centre for Biomedical Sciences, U.A.E. University, Al Ain, United Arab Emirates., Shelton H; Pirbright Institute, Woking, United Kingdom.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 18; Vol. 15, pp. 1352022. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Factor H*/metabolism , Complement Factor H*/immunology , Influenza, Human*/immunology , Influenza, Human*/virology , Influenza, Human*/metabolism , Influenza A virus*/immunology , Influenza A virus*/physiology , Protein Binding* , Hemagglutinin Glycoproteins, Influenza Virus*/metabolism , Hemagglutinin Glycoproteins, Influenza Virus*/immunology, Humans ; Animals ; Binding Sites ; Influenza in Birds/virology ; Influenza in Birds/immunology ; Influenza in Birds/metabolism ; Birds/virology ; Host-Pathogen Interactions/immunology ; Influenza A Virus, H3N2 Subtype/immunology ; Influenza A Virus, H9N2 Subtype/immunology

المؤلفون: Giralt L; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain., Figueras-Roca M; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain., Eguileor BL; Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain., Romero B; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain., Zarranz-Ventura J; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain., Alforja S; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain., Santiago F; Servei d'Immunologia, Centre de Diagnostic Biomèdic, Hospital Clínic Barcelona, Barcelona, Spain., Bolaños J; Servei d'Immunologia, Centre de Diagnostic Biomèdic, Hospital Clínic Barcelona, Barcelona, Spain., Lozano F; Servei d'Immunologia, Centre de Diagnostic Biomèdic, Hospital Clínic Barcelona, Barcelona, Spain.; Group of Immunoreceptors of the Innate and Adaptive Systems, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Departament de Biomedicina, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain., Dotti-Boada M; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain., Sala-Puigdollers A; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain., Dura P; Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain., Izquierdo-Serra J; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain., Valero O; Servei d'Estadística, Universitat Autònoma de Barcelona, Barcelona, Spain., Adan A; Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona, Spain.; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain., Fonollosa A; Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.; Department of Retina, Instituto Oftalmológico Bilbao, Bilbao, Spain., Molins B; Group of Ocular Inflammation: Clinical and Experimental Studies, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 03; Vol. 15, pp. 1330913. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: C-Reactive Protein*/analysis , C-Reactive Protein*/metabolism , Complement Factor H*/analysis , Complement Factor H*/metabolism , Macular Degeneration*/diagnosis , Macular Degeneration*/metabolism, Female ; Humans ; Male ; Biomarkers ; Cross-Sectional Studies